Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2348446
Max Phase: Preclinical
Molecular Formula: C16H13N5O2
Molecular Weight: 307.31
Molecule Type: Small molecule
Associated Items:
ID: ALA2348446
Max Phase: Preclinical
Molecular Formula: C16H13N5O2
Molecular Weight: 307.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cnn2c1n[n+]([O-])c1ccc(OCc3ccncc3)cc12
Standard InChI: InChI=1S/C16H13N5O2/c1-11-9-18-20-15-8-13(23-10-12-4-6-17-7-5-12)2-3-14(15)21(22)19-16(11)20/h2-9H,10H2,1H3
Standard InChI Key: GSQMITXEUGIGFD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 307.31 | Molecular Weight (Monoisotopic): 307.1069 | AlogP: 1.80 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.25 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.00 | CX LogP: 2.04 | CX LogD: 2.03 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.43 | Np Likeness Score: -1.00 |
1. Guerrini G, Ciciani G, Costanzo A, Daniele S, Martini C, Ghelardini C, Di Cesare Mannelli L, Ciattini S.. (2013) Synthesis of novel cognition enhancers with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at γ-aminobutyric acid type A (GABA(A)) receptor., 21 (8): [PMID:23490154] [10.1016/j.bmc.2013.02.027] |
Source(1):